Fig. 5From: Polylactic acid-based electrospun fiber and hyaluronic acid-valsartan hydrogel scaffold for chronic wound healinga Representative images of wounds as days elapsed showing marked difference between varying PLA/HA-valsartan scaffolds VA, VB, VC, and VC, no treatment group cover with gauze and conventional treatment Sofratulle gauze containing fraymycetin sulfate BP 1%. b Representative sections stained with hematoxylin and eosin 15 days post-treatment (H&E). c Percentage wound contraction in the animals treated with varying PLA/HA-valsartan scaffolds and control. N = 4Back to article page